title: Cancer stem cells: a new approach to tumor development.
abstract: Many theories have been proposed to explain the origins of cancer. Currently, evidences show that not every tumor cell is capable of initiating a tumor. Only a small part of the cancer cells, called cancer stem cells (CSCs), can generate a tumor identical to the original one, when removed from human tumors and transplanted into immunosuppressed mice. The name given to these cells comes from the resemblance to normal stem cells, except for the fact that their ability to divide is infinite. These cells are also affected by their microenvironment. Many of the signaling pathways, such as Wnt, Notch and Hedgehog, are altered in this tumoral subpopulation, which also contributes to abnormal proliferation. Researchers have found several markers for CSCs; however, much remains to be studied, or perhaps a universal marker does not even exist, since they vary among tumor types and even from patient to patient. It was also found that cancer stem cells are resistant to radiotherapy and chemotherapy. This may explain the re-emergence of the disease, since they are not completely eliminated and minimal amounts of CSCs can repopulate a tumor. Once the diagnosis in the early stages greatly increases the chances of curing cancer, identifying CSCs in tumors is a goal for the development of more effective treatments. The objective of this article is to discuss the origin of cancer according to the theory of stem cell cancer, as well as its markers and therapies used for treatment.
authors.affiliation: United Metropolitan Colleges, São Paulo, SP, Brazil.
authors.forename: Natália Cristina Ciufa
authors.initials: NC
authors.lastname: Kobayashi
authors.affiliation: Department of Allergy and Immunology, University of São Paulo, São Paulo, SP, Brazil.
authors.forename: Samuel Marcos Ribeiro de
authors.initials: SM
authors.lastname: Noronha
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor; D006801:Humans; D051379:Mice; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D014411:Neoplastic Stem Cells; D015398:Signal Transduction; D055153:Stem Cell Niche
chemical_list: D014408:Biomarkers, Tumor